ESYT1 and cancer: Acting via E-Syt1 (Extended Synaptotagmin-1), the lipid transport protein, ANKRD22 stimulates lipid transport into mitochondria and reduces the number of mitochondria, thus further promoting the reprogramming of cancer cells to meet their metabolic requirements [96].